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The dissection of the interaction nodes between genome and
environment is a long-standing challenge in biomedical
research, and how much these two components individually
contribute to human health remains currently elusive. The
BRCA1-associated protein 1 (BAP1) is an example of a critical
player in determining the outcome of the interaction of Genes
versus Environment and two recent studies coordinated by a
collaboration of the Carbone, Pinton, Yang and Jia groups
provide a mechanistic rationale for the contribution of BAP1 to
carcinogen sensitivity.1,2
BAP1 is an ubiquitin C-terminal hydrolase belonging to a
larger group of deubiquitylating enzymes.3 Original studies by
Carbone’s group identified the association of germline
mutations in BAP1 with early onset of benign melanocytic
skin tumours and a later high incidence of malignant
mesothelioma together with uveal and cutaneous
melanoma.4–6 The study conducted on two unrelated US
families, referred to as ‘L’ and ‘W’ for their origins from
Louisiana and Wisconsin respectively, implicated the 3p21
chromosomal region with an unexpectedly high incidence of
malignant mesothelioma following minimal exposure to
asbestos.2 Sequencing of this locus led to the identification
of heterozygous mutations in BAP1, uncovering a novel
familial autosomal dominant cancer syndrome. Indeed,
biallelic somatic mutations in BAP1 are also frequently
observed in human cancers.7,8 Nearly all cancer types have
been reported in carriers of BAP1 germline mutations, but the
high incidence of tumours associated with environmental
stressors, such as mesothelioma (with asbestos), melanoma
and skin tumours (with UV), highlights BAP1 as a critical
player in the interaction of genes with environment.
Despite the critical relevance of BAP1 for cancer predis-
position, the mechanistic insights underlining its function have
so far been elusive. Originally identified in a yeast two‐hybrid
screen as an interactor of the RING finger domain of the
tumour suppressor BRCA1, BAP1 was eventually disproved
as a BRCA1 deubiquitylating enzyme.3 Nuclear BAP1 indeed
deubiquitylates BRCA1‐associated RING domain 1 (BARD1),
which in a heterodimer with BRCA1, forms the E3 ubiquitin
ligase that regulates the DNA damage response (DDR).9,10
Loss of BAP1 resembles BRCA1 deficiency, resulting in
hypersensitivity to ionising radiation.3 However, an important
unexplored aspect of BAP1 is the significant proportion of the
protein that can be sequestered in the cytoplasm by multi-
monoubiquitylation of its nuclear localisation signal. In this
study Bononi et al. uncovered a cytoplasmic function of BAP1,
implicating a novel mechanism for the contribution of BAP1
loss to environmental carcinogenesis.
The authors employed an elegant experimental approach,
using BAP1+/− and BAP1+/+ fibroblasts derived from carriers
and control members of families ‘W’ and ‘L’. BAP1+/− fibrob-
lasts express 50% BAP1 protein levels as compared to control
fibroblasts, and represent an excellent cellular model to
experimentally recapitulate BAP1 deficiency in pre-carcino-
genic conditions. In the work published in Nature1 the authors
showed in subcellular fractionation experiments a significant
accumulation of BAP1 in the cytoplasm and more specifically
in the endoplasmic reticulum (ER). A reduced level of BAP1 in
BAP1+/− fibroblasts mainly affected the ER fraction of the
protein, suggesting a potential dysfunction of the ER in the
mutant cells.1 As BAP1+/− cells appeared hyposensitive to a
wide range of pro-apoptotic drugs and inducers, the authors
speculated that BAP1 may contribute to control of the pro-
apoptotic Ca2+ release from the ER. BAP1+/− fibroblasts
indeed displayed a reduced level of Ca2+ release from the ER,
which was restored by re-expression of chimeric BAP1
mutants selectively targeting ER and cytoplasm, but not the
nucleus. Thus, Carbone et al. reported an unanticipated
cytoplasmic function of BAP1 that could explain its critical role
in determining the biological outcome of its interaction with the
environmental stressors.1
As a ubiquitin hydrolase, BAP1 exerts an enzymatic activity
which directly influences stability and activation of its
substrates. Investigating the cytoplasmic function of BAP1,
the authors focused on the possible interaction between BAP1
and ER channels that control Ca2+ flux to the cytoplasm.
The data clearly indicated that BAP1 physically interacts with
the type-3 inositol-1,4,5-trisphosphate-receptor (IP3R3), and
BAP1 expression level is directly correlated with IP3R3 in
wild-type and mutant fibroblasts. Deeper biochemical analysis
indeed demonstrated that BAP1 enzymatically controls IP3R3
ubiquitination and thus positively influences its stability. Loss
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of BAP1 therefore results in reduced expression of IP3R3 with
correspondingly reduced cytoplasmic Ca2+ release, which in
turn determines resistance to apoptotic inducers. The authors
also observed an increase of cytoplasmic Ca2+ release and
apoptosis in crocidolite asbestos-treated primary human
mesothelial cells. Remarkably, depletion of BAP1 or IP3R3
promoted crocidolite asbestos/TNF-α-induced transformation
of primary mesothelial cells, and re-expression of IP3R3 in
BAP1-depleted cells partially reverted the phenotype.1 How-
ever, experimentswith subcellular specific chimeric mutants of
BAP1 indicated that both nuclear and cytoplasmic BAP1
contributed to the phenotype. This latter data opens the
question regarding the specific contribution of the balance
between cytoplasmic and nuclear BAP1 to cell death and
genomic stability upon interaction with environmental
stressors.
A second study published inCell Death & Differentiation2 by
the same groups reports an intriguing observation in BAP1+/−
individuals, which might shed light on the molecular basis of
the transformation potential of these cells.2 By metabolic
profiling of fibroblasts and plasma of carriers and control
members from ‘W’ and ‘L’ families, the authors identified a
clear alteration in cellular metabolism adopted by the mutant
cells. BAP1+/− fibroblasts displayed a typical ‘Warburg effect’,
as their cellular metabolism largely relied on aerobic glyco-
lysis, increased lactate production and reduced mitochondrial
respiration.2 Metabolic profiling of plasma from carrier
individuals also displayed a similar distribution of the
metabolites, and their profile was predictive of the genotype
with 100% accuracy. The originality of these data relies on the
observation of metabolic rewiring typical of transformed cells
in a premalignant cellular setting, thus suggesting that that
‘Warburg effect’ might facilitate cancer transformation rather
than be an adaptive process occurring in malignancy.Whether
the observedmetabolic change is associated with alteration of
the Ca2+ flux and ER/mitochondria function of BAP1+/− cells
will require further investigation and will probably highlight
additional layers of complexity on the contribution of BAP1
deficiency to carcinogen hypersensitivity.
In conclusion, these studies have clarified novel important
molecular aspects associated with the cancer predisposition
of BAP1+/− carrying individuals and suggest new relevant
questions, related to BAP1-dependent cancer susceptibility,
and to more general gene/environment interactions (Figure 1).
It is now important to fully dissect the relative contribution of
cytoplasmic versus nuclear BAP1 to the different aspects of
carcinogenesis. In line with this, additional molecular details
are required in relation to the control of BAP1 function, as, for
example, whether and which (micro)-environmental signals
can trigger BAP1 subcellular localisation and consequentially
balance its contribution to genomic stability and cell death.
Also, it will be important to assess the contribution of BAP1
somatic mutations to the tumorigenic process, and whether
their incidence correlates with a selective mutational land-
scape. In addition, the contribution of premalignant metabolic
rewiring to tumour transformation will stimulate a broad
interest in the field. This aspect might also have wider
implications for the genes− environment interaction, as it
might imply that dietary regimes could influence metabolism
and cellular transformation in specific predisposed conditions
such as BAP1 mutations. Finally, these studies further
highlight the importance of the integration of multidisciplinary
Figure 1 BAP1 is a ubiquitin C-terminal hydrolase belonging to the larger group of deubiquitylating enzymes. Germline mutations in BAP1 gene identify a multi-cancer
syndrome associated with onset of most types of malignancies and extremely high incidence of tumours related to environmental carcinogens, such as malignant mesothelioma
(from asbestos), and uveal and cutaneous melanomas (from UV). The study by Carbone et al. describes a novel cytoplasmic function of BAP1. BAP1 controls ubiquitylation and
stability of the endoplasmic reticulum (ER) Ca2+ channel, IP3R3. Deficiency of BAP1 is indeed associated to reduction of cytoplasmic Ca2+ upon pro-apoptotic stress and
consequent reduced mitochondrial cell death. Concurrent impaired nuclear activity of BAP1 cooperates with the altered ER function resulting in resistance to apoptosis and
promotion of tumour transformation. Overall this determines increased susceptibility to carcinogenesis. Residual expression of truncated forms of BAP1 can occur in BAP1+/−
cells; these are sequestered in the cytoplasm and lose interaction capacity with IP3R3. A second study by Carbone describes a peculiar metabolic rewiring of non-malignant
BAP1+/− cells. BAP1+/− fibroblasts from carrier individuals display elevated aerobic glycolysis, high lactate production and reduced mitochondrial respiration. This metabolic
profile is compatible with the ‘Warburg effect’ typically associated with malignancy. Whether and how this metabolic rewiring contributes to cancer predisposition in BAP1−/+
carriers will require further studies
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approaches to dissect the interactions between genetic and
environmental factors, to translate this information and stratify
patients for prevention and treatment, and to provide novel
biomarkers that predict risk of exposure.
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